The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice

The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was the first trial to assess whether statins might be of clinical benefit in those with recently unstable coronary disease. MIRACL found that high-dose atorvastatin was safe and reduced the incidence of the compos...

Descripción completa

Detalles Bibliográficos
Autor principal: Aronow, Herbert D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134475/
https://www.ncbi.nlm.nih.gov/pubmed/11985777
http://dx.doi.org/10.1186/1468-6708-3-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134475/
https://www.ncbi.nlm.nih.gov/pubmed/11985777
http://dx.doi.org/10.1186/1468-6708-3-3

Ejemplares similares